Wellington Management Group’s Evogene EVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-15,759
Closed -$803K 2256
2016
Q4
$803K Sell
15,759
-8,546
-35% -$489K ﹤0.01% 1912
2016
Q3
$1.53M Sell
24,305
-2,716
-10% -$179K ﹤0.01% 1728
2016
Q2
$1.68M Buy
27,021
+1,431
+6% +$99.7K ﹤0.01% 1647
2016
Q1
$1.69M Sell
25,590
-1,885
-7% -$129K ﹤0.01% 1647
2015
Q4
$2.2M Buy
27,475
+4,653
+20% +$346K ﹤0.01% 1598
2015
Q3
$1.88M Buy
22,822
+5,703
+33% +$497K ﹤0.01% 1654
2015
Q2
$1.51M Sell
17,119
-475
-3% -$46K ﹤0.01% 1747
2015
Q1
$1.55M Sell
17,594
-385
-2% -$35.9K ﹤0.01% 1756
2014
Q4
$1.66M Sell
17,979
-4,636
-20% -$491K ﹤0.01% 1735
2014
Q3
$2.95M Sell
22,615
-519
-2% -$71.6K ﹤0.01% 1585
2014
Q2
$3.77M Sell
23,134
-3,807
-14% -$655K ﹤0.01% 1530
2014
Q1
$5.14M Sell
26,941
-1,961
-7% -$372K ﹤0.01% 1446
2013
Q4
$5.68M Buy
+28,902
New +$5.34M ﹤0.01% 1420

Other funds holding EVGN

Wellington Management Group's EVGN Position: Q1 2017 in Review

Wellington Management Group sold out of Evogene (EVGN) in Q1 2017, closing a stake of 15,759 shares — an estimated $803K sold.

Wellington Management Group first reported a position in EVGN in Q4 2013 and held it in 13 quarters. The position peaked at $5.68M in Q4 2013. 22 funds tracked by Wall St. Rank hold EVGN as of Q1 2017.

  • Wellington Management Group reported no remaining Evogene position as of Q1 2017 after selling out during the quarter.
  • Wellington Management Group sold 15,759 Evogene shares in Q1 2017, an estimated $803K.
  • Wellington Management Group first reported a position in Evogene in Q4 2013 and held it in 13 quarters.
  • Wellington Management Group's Evogene position peaked at $5.68M in Q4 2013.
  • 22 funds tracked by Wall St. Rank held Evogene as of Q1 2017.

Based on Wellington Management Group's 13F filing for Q1 2017, filed 11 May 2017.